SOLVE-TAVI after 12-month followup: self-expanding vs. balloon expandable and general vs. local anesthesia

The ambitious SOLVE-TAVI (soon to be published in JACC) is aimed at answering to of the most important questions we make when facing a TAVR procedure: What valve do we choose, a self-expanding or a balloon expandable? And once we have chosen our device, do we proceed with general anesthesia or conscious sedation? 

Sedación consciente vs anestesia general en el TAVI

 

The SOLVE-TAVI had already shown no major differences at 30 days between devices or sedation strategies. At present, after one year, we look forward to these results. 

Using a 2 × 2 factorial design, 447 intermediate to high-risk patients with severe, symptomatic aortic stenosis were randomly assigned to transfemoral TAVR using the self-expanding Evolut R vs. the balloon expandable Sapien 3.  Following the 2 x 2 design, patients were randomized to general anesthesia vs. conscious sedation at the same time. 

When comparing devices, the combined end point rate (all-cause mortality, stroke, moderate to severe paravalvular leak and need of permanent pacemaker implantation) resulted similar between prosthesis at one year (38.3% vs 40.4%, HR 0.94, CI 95% 0.7 to 1.26; p=0.66).

As regards sedation, outcomes were as disappointing: general anesthesia resulted similar to conscious sedation when it came to the combined end point of all-cause mortality, stroke, MI and acute kidney injury (25.7% vs 23.8%, HR 1.09, CI 95% 0.76 to 1.57; p=0.63).


Read also: TCT 2018 | SOLVE-TAVI: Self-Expandable vs. Balloon-Expandable Valves and General vs. Local Anesthesia in One Study.


Probablemente, para la enorme mayoría de los pacientes la elección de la válvula o el tipo de anestesia todavía pase por la experiencia de cada operador y equipo. Sin embargo, existen diferencias sutiles de subgrupos que pueden inclinar la balanza hacia una u otra válvula como también al tipo de anestesia.

Conclusión

En pacientes de riesgo intermedio o alto que reciben TAVI transfemoral no se observaron diferencias al año entre las actuales generaciones de la válvula autoexpandible y la válvula balón expandible. Los tipos de anestesia tampoco mostraron diferencias significativas en el mismo período de tiempo.

Título original: Impact of Anesthesia Strategy and Valve Type on Clinical Outcomes After Transcatheter Aortic Valve Replacement.

Referencia: Hans-Josef Feistritzer et al. J Am Coll Cardiol. 2021 May, 77 (17) 2204–2215.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....